GSX Platform Introduces Improved FDA 21 CFR Part 11 Capability

The new GSX software release offers enhanced FDA 21 CFR Part 11 capability.

The new GSX software release offers enhanced FDA 21 CFR Part 11 capability.
The new GSX software release offers enhanced FDA 21 CFR Part 11 capability.
Emerson

The GSX-E1 is an ultrasonic welding solution for low-force delicate applications across the medical industry. Its electro-mechanical actuation system, coupled with its ergonomic user interface, gives customers the tools to achieve optimum weld results such as welder-welder repeatability (measured in microns) and zero production rejects, which ultimately saves customers time and money.

The GSX platform continues to expand its capabilities with production processes that are aligned with the Food and Drug Administration’s (FDA) regulations. The new GSX software release offers enhanced FDA 21 CFR Part 11 capability, improved welder security, data traceability, and data retention of up to 200,000 parts per production batch, which is critical for medical customers. This software enhancement comes standard across the GSX-E1 product lines and is compatible with Industry 4.0 and automated environments.

Latest in New Products
More in New Products